Microfluidic Antibody Microarray with Code-Multiplexed Coulter Counters

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current immunophenotyping methods, such as flow cytometry, are limited by the number of antigens they can simultaneously probe and require bulky, expensive instrumentation, making them unsuitable for point-of-care applications, while microfluidic devices face challenges in integrating multiple electrical sensors and selective functionalization for multiplexed assays.

Innovation Solution

A microfluidic antibody microarray with an integrated electrical sensor network, featuring an array of microfluidic cell capture chambers functionalized with different antibodies and a network of code-multiplexed Coulter counters, allows for simultaneous detection and quantification of cell populations without increasing device complexity.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If flow cytometry is used for immunophenotyping, then measurement precision is improved, but device complexity and cost increase

Engineering Contradiction:
Improvequantification accuracyVSAvoidinstrumentation complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent replaces the optical detection system of flow cytometry with an electrical sensing system based on Coulter counters. The microfluidic device uses electrical impedance measurements to detect and quantify cell populations, substituting complex optical components (lasers, photodetectors, fluorescence filters) with simpler electrical electrodes and signal processing circuitry, thereby reducing device complexity while maintaining quantification capability

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent creates a simplified electrical copy of the flow cytometry detection principle. Instead of measuring light scattering and fluorescence emission, the system uses electrical impedance changes to infer cell presence and characteristics, providing a functional equivalent with reduced complexity

Inventive Principle:
Principle #26Copying

2Adaptability or versatility

If multiple electrical sensors are integrated into microfluidic device, then measurement capability is improved, but device complexity increases

Engineering Contradiction:
Improvemultiplexed detection capabilityVSAvoidsensor integration complexity
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The patent merges multiple sensing functions into a unified electrical sensor network within the microfluidic device. By integrating multiple Coulter counter electrodes and combining their signals through code-multiplexing, the system achieves multiplexed detection of different cell populations while managing complexity through signal integration rather than separate detection systems

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The patent implements a universal electrical sensing platform that can detect multiple cell types and antigens through a single integrated sensor network. The same basic Coulter counter principle is applied across multiple sensing zones, with versatility achieved through selective antibody functionalization rather than diverse sensor types, reducing integration complexity

Inventive Principle:
Principle #6Universality (Multi-functionality)

3Productivity

If code-multiplexed Coulter counters are used, then productivity is improved, but manufacturing precision requirements increase

Engineering Contradiction:
Improvecell quantification throughputVSAvoidelectrode positioning accuracy
Core Design Contradiction:
ProductivityVSManufacturing precision

Solution Approach 1:

The patent incorporates feedback mechanisms in the signal processing chain of the code-multiplexed Coulter counters. By using correlation detection and code-based signal identification, the system can tolerate certain variations in electrode positioning and timing, as the feedback processing corrects and identifies the intended signal patterns, reducing the stringency of manufacturing precision requirements

Inventive Principle:
Principle #23Feedback

Solution Approach 2:

The patent uses parameter changes in the electrical signaling (code-multiplexing with distinct temporal or amplitude codes) to differentiate between multiple sensing channels. This allows the system to achieve high productivity through parallel detection while being more tolerant of manufacturing variations, as the distinction between channels is encoded in signal parameters rather than requiring perfectly precise physical separation

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables immunophenotyping at the point of care with reduced equipment size and operational complexity, providing accurate quantification of cell subpopulations through electrical coding of cell capture statistics, comparable to flow cytometry and hematology analyzers.

Implementation Method 1

a network of code-multiplexed Coulter counters placed at strategic nodes across the device to quantify the fraction of cell population captured in each microfluidic chamber

Methodology Applied
Scientific EffectCoulter counter: Coulter Counter

Implementation Method 2

an array of microfluidic cell capture chambers, each functionalized with a different antibody to recognize a target antigen

Methodology Applied
Scientific EffectImmunological binding: Adsorption

Data Source

PatentUS12370548B2Microfluidic antibody microarray with an electronic sensor array
Publication Date: 2025.07.29 GEORGIA TECH RES CORP
  • US12370548B2 patent drawing
  • US12370548B2 patent drawing
  • US12370548B2 patent drawing

AI summary

Embodiments of the microfluidic device may include of an array of microfluidic cell capture chambers, each functionalized with a different antibody to recognize a target antigen, and a network of code-multiplexed Coulter counters placed at strategic nodes across the device to quantify the fraction of cell population captured in each microfluidic chamber. For example, an apparatus may comprise a fluid inlet port divided into a plurality of separate microfluidic paths, each separate microfluidic path configured to transport a plurality of cells, the plurality of separate microfluidic paths, each comprising a plurality of microfluidic cell capture chambers, an outlet port to discharge a merged output of cells from the plurality of microfluidic cell capture chambers, and a plurality of sensors to detect cells passing into or out of a microfluidic cell capture chamber.